The Board denied an earlier effective date for the 60 percent rating for prostate cancer residuals, finding no evidence that the Veteran needed to change absorbent materials more than four times per day prior to August 9, 2022.
The deciding factor: The Board found no clinical evidence or statements from the Veteran indicating he required absorbent materials changed more than four times a day before the VA examination on August 9, 2022.
- Claimed conditions
- prostate cancer residuals
- How they argued it
- Direct service connection
- Exposure basis
- None
- Rating assigned
- None in this decision
- Decision date
- November 7, 2024
- Citation
- A24072934
What this means for you
A denial is a starting point, not the end of the road. You can see why this claim fell short — and, if you are still inside the one-year window, the appeal lanes that may remain open to you.
What you can do next
Related decisions
Other Board decisions on a similar condition or argued the same way.
- Partly granted
The Board granted a 40 percent evaluation for prostate cancer residuals from January 29, 2014 to August 12, 2021.
- Denied
The Board denied the Veteran's claim for a total disability rating based on individual unemployability (TDIU) due to his service-connected disabilities, including prostate cancer residuals, hearing loss, tinnitus, and erectile dysfunction.
- Dismissed
The appeal of a proposal to reduce the rating for service-connected prostate cancer residuals from 100 percent to 40 percent is dismissed as it was not a final decision.
- Granted
The Veteran's prostate cancer residuals are granted a 60 percent rating from July 7, 2023.
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.